News
Oct 25, 2018 | News
Representatives from the Eswatini Ministry of Health on October 25, 2018, officially launched a groundbreaking study of a new, long-acting, injectable drug for the prevention of HIV infection. This is the first investigational drug trial testing a new form of...
Oct 24, 2018 | In the Media, News
“HPTN 075 provides compelling findings that indicate an urgent need for further HIV prevention studies for men who have sex with men and transgender women in sub-Saharan Africa,” said Wafaa El-Sadr MD, MPH, MPA, HPTN co-principal investigator and professor...
Sep 28, 2018 | In the Media, News
Dr. Elaine J. Abrams, ICAP’s senior research director and professor of epidemiology and pediatrics at Columbia University Mailman School of Public Health and the Vagelos College of Physicians & Surgeons, was awarded a National Institutes of Health (NIH) grant to...
Sep 24, 2018 | In the Media, News
As it celebrates its 15th year, ICAP has five new Mailman School of Public Health faculty on its team: Maria Lahuerta, Matthew Lamb, Andrea Low, Harriet Nuwagaba-Biribonwoha, and Bill Reidy. “Over the years, more options for effective and safer HIV medicines have...
Sep 18, 2018 | News
Jorge Soler, PhD, MPH, is a community-based researcher at heart. Having spent five years working at a health agency serving the Latino community of Boston before starting his public health research training at the University of Michigan, his research is...
Sep 18, 2018 | News
Recognizing that antiretroviral therapy (ART) “keeps people living with HIV alive, healthier and reduces the risk of transmitting the virus to partners,” the World Health Organization in 2015 recommended that anyone infected with HIV should begin ART as soon after...